In conclusion, we demonstrated that DHX9 was elevated in gliomas and promoted the proliferation, migration, invasion of glioma cells, and the infiltration of TAMs by targeting the TCF12/CSF1 axis. Here, CSF1 is linked to central nervous system cancer.